196 related articles for article (PubMed ID: 30508623)
21. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
[TBL] [Abstract][Full Text] [Related]
22. [Effect of Kangquan Recipe on apoptosis regulatory genes bax and bcl-2 mRNA in prostate of rats].
Huang YP; Du J; Hong ZF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):711-4. PubMed ID: 17879535
[TBL] [Abstract][Full Text] [Related]
23. LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.
Rick FG; Schally AV; Block NL; Halmos G; Perez R; Fernandez JB; Vidaurre I; Szalontay L
Prostate; 2011 May; 71(7):736-47. PubMed ID: 20945403
[TBL] [Abstract][Full Text] [Related]
24. [Effect of PI3K/AKT inhibitor on benign prostate hyperplasia and its mechanism: an experimental study].
Jin P; Wang YH; Peng YG; Hu S; Lu Q; Yang LY
Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1068-75. PubMed ID: 21348195
[TBL] [Abstract][Full Text] [Related]
25. Oral exposure to low-dose bisphenol A aggravates testosterone-induced benign hyperplasia prostate in rats.
Wu JH; Jiang XR; Liu GM; Liu XY; He GL; Sun ZY
Toxicol Ind Health; 2011 Oct; 27(9):810-9. PubMed ID: 21415097
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effect of D-004, a lipid extract from Roystonea regia fruits, on prostate hyperplasia induced in rats.
Carbajal D; Molina V; Mas R; Arruzazabala ML
Drugs Exp Clin Res; 2005; 31(5-6):193-7. PubMed ID: 16425975
[TBL] [Abstract][Full Text] [Related]
27. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
[TBL] [Abstract][Full Text] [Related]
28. Ameliorative effects of stinging nettle (Urtica dioica) on testosterone-induced prostatic hyperplasia in rats.
Nahata A; Dixit VK
Andrologia; 2012 May; 44 Suppl 1():396-409. PubMed ID: 21806658
[TBL] [Abstract][Full Text] [Related]
29. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
30. [Effect of fenghuaqianqingcha on experimentally induced prostatic hyperplasia in mice].
Rao X; Bao L; Feng X; Yao N; Xie G; Hiroshi K
Zhong Yao Cai; 2008 Sep; 31(9):1381-5. PubMed ID: 19180964
[TBL] [Abstract][Full Text] [Related]
31. The combination of Serenoa repens, selenium and lycopene is more effective than serenoa repens alone to prevent hormone dependent prostatic growth.
Altavilla D; Bitto A; Polito F; Irrera N; Marini H; Arena S; Favilla V; Squadrito F; Morgia G; Minutoli L
J Urol; 2011 Oct; 186(4):1524-9. PubMed ID: 21855911
[TBL] [Abstract][Full Text] [Related]
32. Effects of Kangquan Recipe on sex steroids and cell proliferation in rats with benign prostatic hyperplasia.
Huang YP; Du J; Hong ZF; Chen ZQ; Wu JF; Zhao JY
Chin J Integr Med; 2009 Aug; 15(4):289-92. PubMed ID: 19688318
[TBL] [Abstract][Full Text] [Related]
33. In vivo evaluation of hot water extract of Acorus gramineus root against benign prostatic hyperplasia.
Moon JM; Sung HM; Jung HJ; Seo JW; Wee JH
BMC Complement Altern Med; 2017 Aug; 17(1):414. PubMed ID: 28830494
[TBL] [Abstract][Full Text] [Related]
34. Ulmus macrocarpa Hance trunk bark extracts inhibit RANKL-induced osteoclast differentiation and prevent ovariectomy-induced osteoporosis in mice.
Jeong C; Lee CH; Lee Y; Seo J; Wang W; Park KH; Oh E; Cho Y; Park C; Son YJ; Yoon Park JH; Kang H; Lee KW
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117285. PubMed ID: 37839769
[TBL] [Abstract][Full Text] [Related]
35. Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.
Altavilla D; Minutoli L; Polito F; Irrera N; Arena S; Magno C; Rinaldi M; Burnett BP; Squadrito F; Bitto A
Br J Pharmacol; 2012 Sep; 167(1):95-108. PubMed ID: 22471974
[TBL] [Abstract][Full Text] [Related]
36. Management of experimental benign prostatic hyperplasia in rats using a food-based therapy containing Telfairia occidentalis seeds.
Ejike CE; Ezeanyika LU
Afr J Tradit Complement Altern Med; 2011; 8(4):398-404. PubMed ID: 22654217
[TBL] [Abstract][Full Text] [Related]
37. Fermented rape pollen powder can alleviate benign prostatic hyperplasia in rats by reducing hormone content and changing gut microbiota.
Han YY; Zhang QH; Chen WS; Li ZL; Xie D; Zhang SL; Lu H; Wang LW; Xu ZH; Zhang LZ
Benef Microbes; 2023 Nov; 14(5):503-524. PubMed ID: 38656098
[TBL] [Abstract][Full Text] [Related]
38. Possible therapeutic role of zinc oxide nanoparticles versus vanillic acid in testosterone-induced benign prostatic hyperplasia in adult albino rat: A histological, immunohistochemical and biochemical study.
Abdel Fattah S; Ibrahim MEE; El-Din SS; Emam HS; Algaleel WAA
Life Sci; 2023 Dec; 334():122190. PubMed ID: 37866805
[TBL] [Abstract][Full Text] [Related]
39. Red ginseng and 20(S)-Rg3 control testosterone-induced prostate hyperplasia by deregulating androgen receptor signaling.
Bae JS; Park HS; Park JW; Li SH; Chun YS
J Nat Med; 2012 Jul; 66(3):476-85. PubMed ID: 22101440
[TBL] [Abstract][Full Text] [Related]
40. Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation.
Ma Z; Hung Nguyen T; Hoa Huynh T; Tien Do P; Huynh H
J Endocrinol; 2004 Jun; 181(3):493-507. PubMed ID: 15171697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
